Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02284919 · ClinicalTrials.gov registry record · Phase 1

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer

A Phase 1 study of Breast Cancer and Breast Neoplasm, sponsored by University of Pennsylvania.

Active
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT02284919 is a Phase 1 study of Breast Cancer and Breast Neoplasm that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02284919, a Phase 1 study of Breast Cancer and Breast Neoplasm, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2 (σ2) receptor activity in sites of primary breast cancer using the investigational radiotracer \[18F\]ISO-1.

Conditions Studied

Breast Cancer Breast Neoplasm

Interventions

  • DRUG [18F]ISO-1

Study Locations (1)

Pennsylvania

  • University of Pennsylvania Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-03-11
Est. Completion 2026-11
Phase Phase 1

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02284919

The ClinicalTrials.gov registry entry for NCT02284919 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which [18F]ISO-1 is the first listed.

NCT02284919 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02284919 about?

NCT02284919 is a clinical study titled "[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer". In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2 (σ2) receptor activity in sites of primary breast cancer using the investigational radiotracer \[18F\]ISO-1.

What is the current status of trial NCT02284919?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2015-03-11. Estimated completion is 2026-11.

What conditions does trial NCT02284919 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasm.

What interventions are being tested in trial NCT02284919?

The interventions under investigation include: [18F]ISO-1 (DRUG).

Who is sponsoring clinical trial NCT02284919?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02284919 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Breast Neoplasm

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.